Hematology NewsLess lenalidomide may be more in frail elderly multiple myeloma patientsJuly 27, 2017Lymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsFLT3-L level may point to relapsed/refractory multiple myelomaJuly 26, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsFour drugs better than three for myeloma inductionJuly 25, 2017Multiple MyelomaCellular TherapyLymphoma & Plasma Cell Disorders
Hematology TimesKRD appears more active, less safe than KCD in newly diagnosed MMJuly 25, 2017Multiple Myeloma
Hematology TimesAYA cancer survivors struggle with social functioningJuly 21, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated Issues
Hematology NewsFDA okays ClearLLab test for hematologic cancer detectionJuly 11, 2017Multiple MyelomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMyelodysplastic Syndrome
Hematology NewsTool indicates fracture risk after HSCTJuly 10, 2017Multiple MyelomaPatient & Survivor CareCellular Therapy
Hematology TimesCommon insurance plans exclude NCI, NCCN cancer centersJuly 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology Nursing
Hematology TimesFDA clears use of reagents to detect hematopoietic neoplasiaJuly 3, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAggressive Lymphomas
Hematology TimesSingle-dose NEPA found non-inferior to aprepitant/granisetronJune 29, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated IssuesHodgkin LymphomaNon-Hodgkin Lymphoma
